Broad Market Exposure
Five hundred large US companies in one position.
A machine learning strategy that manages broad US market exposure through SPYx, with rule-based drawdown control.
xStocks are not available in every country and may require an appropriateness assessment.
The US market compounds well over decades. It also delivers drawdowns that take years to recover. Investors who sell during those periods rarely return in time to capture the recovery.
The US Equity Strategy sizes exposure by rule. It stays invested while conditions support it and steps back when they do not.
Stay invested through ordinary volatility.
Reduce exposure during sustained market declines.
Re-enter on evidence, not on sentiment.
Avoid the sell-low, buy-high behaviour loop.
Apply identical rules in every regime.
US Equity Strategy against passive SPYx buy-and-hold.
| Metric | US Equity Strategy | Buy & Hold SPYx |
|---|---|---|
| CAGR | ||
| Total return | ||
| Added return | — | |
| Maximum drawdown | ||
| Volatility |
Scroll horizontally to see all columns.
Backtest period: .
Results are backtested, net of assumed trading costs, and calculated on historical data. Hypothetical performance does not represent actual trading and carries the benefit of hindsight. Full assumptions are documented in each report.
The model reads market data continuously and sets exposure to SPYx accordingly. Favourable conditions mean long exposure. Deteriorating conditions mean reduced or zero exposure.
No discretionary trading.
No emotional decisions.
No guessing.
SPYx is a tokenized tracker of the S&P 500, issued through Kraken's xStocks programme.
Five hundred large US companies in one position.
Access outside traditional exchange sessions.
Invest exact amounts, not whole shares.
Ownership settles on-chain, verifiably.
One instrument, one signal, one position to manage.
Issued and traded through a regulated exchange.
xStocks products carry their own rules. Availability varies by country and EU residents may need to pass Kraken's appropriateness assessment before trading. Review Kraken's documentation before subscribing.
NeuroTraderLab never holds client funds.
Your capital remains in your own verified Kraken account.
The connection places trades. It cannot withdraw funds.
Disconnect or cancel and the signals simply stop.
No management fee. No performance fee. No lock-up.
Exchange trading fees and Cryptohopper platform fees are charged separately by those providers.
The knowledge base walks through the full setup, from account to automation.
A tokenized instrument tracking the S&P 500, issued through Kraken's xStocks programme.
Availability varies. Check Kraken's country availability page before subscribing.
EU residents may need to complete Kraken's appropriateness test for xStocks.
No. Assets stay in your Kraken account.
No. The strategy is investment software.
Signals stop. Your positions and assets remain yours.
Dividend treatment depends on the token issuer, not on the strategy. Check Kraken's documentation.
No. Backtests are hypothetical and carry hindsight bias.
Broad US equity exposure with a defined, rule-based process behind it.
NeuroTraderLab provides investment software, not investment advice. Trading involves risk, including the loss of capital. Backtested and hypothetical performance has inherent limitations: results are calculated with hindsight, do not represent actual trading, and do not account for all costs or market conditions. Past performance does not guarantee future results. Tokenized assets may not be available in all jurisdictions. You are responsible for your own financial decisions and for assessing suitability before investing.
Read the full Risk Disclosure